← FDA Drug Approvals (Drugs@FDA)

POMBILITI

BLA · Biologics License Application · Sponsor: AMICUS THERAP US · Approved 2023-09-28

Drug application

FDA Application #
BLA761204
Application type
Biologics License Application
Brand name
POMBILITI
Generic name
CIPAGLUCOSIDASE ALFA-ATGA
Active ingredients
CIPAGLUCOSIDASE ALFA-ATGA
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
AMICUS THERAP US
Manufacturer
AMICUS THERAPEUTICS US, LLC
First approval
2023-09-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown